Standard Biotools (LAB) Enterprise Value Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.07% |
| Dec 31, 2025 | -21.95% |
| Sep 30, 2025 | -21.58% |
| Jun 30, 2025 | -38.53% |
| Mar 31, 2025 | -39.38% |
| Dec 31, 2024 | -37.18% |
| Sep 30, 2024 | -41.49% |
| Jun 30, 2024 | -41.05% |
| Mar 31, 2024 | -43.90% |
| Dec 31, 2023 | -3.93% |
| Sep 30, 2023 | -29.33% |
| Jun 30, 2023 | -28.77% |
| Mar 31, 2023 | -26.86% |
| Dec 31, 2022 | -21.45% |
| Sep 30, 2022 | -24.45% |
| Jun 30, 2022 | -38.24% |
| Mar 31, 2022 | 9.22% |
| Dec 31, 2021 | 13.09% |
| Sep 30, 2021 | 15.70% |
| Jun 30, 2021 | 18.08% |
| Mar 31, 2021 | 11.82% |
| Dec 31, 2020 | 6.04% |
| Sep 30, 2020 | 5.45% |
| Jun 30, 2020 | 14.20% |
| Mar 31, 2020 | 15.70% |
| Dec 31, 2019 | 12.04% |
| Sep 30, 2019 | 7.41% |
| Jun 30, 2019 | 5.62% |
| Mar 31, 2019 | 12.10% |
| Dec 31, 2018 | -2.49% |
| Sep 30, 2018 | 10.87% |
| Jun 30, 2018 | 7.73% |
| Mar 31, 2018 | 9.89% |
| Dec 31, 2017 | 4.63% |
| Sep 30, 2017 | 6.26% |
| Jun 30, 2017 | -2.11% |
| Mar 31, 2017 | -5.28% |
| Dec 31, 2016 | -2.14% |
| Sep 30, 2016 | -3.87% |
| Jun 30, 2016 | -6.07% |
| Mar 31, 2016 | -11.27% |
| Dec 31, 2015 | -75.39% |
| Sep 30, 2015 | -80.38% |
| Jun 30, 2015 | -65.41% |